Scinai Immunotherapeutics Ltd. (SCNI)

PriceLoading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

7 annual periodsNewest to oldest
2021202020192018201720162015
Research & development₪10.3M₪51.5M₪68.6M₪71.9M₪18.8M₪7.8M₪7.9M
Operating expenses₪78.4M₪77.1M₪23.7M₪11.9M₪11.3M
Net income−₪40.0M−₪4.5M−₪109.2M−₪87.7M−₪34.6M−₪9.2M−₪10.2M
Basic EPSper diluted share-₪0.07-₪0.01-₪0.33-₪0.34-₪0.17-₪0.07-₪0.10
Diluted EPSper diluted share-₪0.33-₪0.34-₪0.17-₪0.07-₪0.10

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.